Estée Lauder Guidance Raised, UBS Maintains Neutral & Raises Target Price to US$85

Overview

UBS released an update report on Estée Lauder (EL.US), stating that after experiencing performance troughs, the company has taken the right steps: FY26 earnings and sales guidance were both raised, and an initial growth and margin target for FY27 was also provided. However, macro environment, geopolitical factors (Middle East conflict), and visibility in China travel retail remain insufficient, thus maintaining a 12-month Neutral rating and raising the target price from US$75 to US$85.

Core views

Regarding Guidance: Estée Lauder raised FY26 EPS guidance from $2.05–2.25 to $2.35–2.45, implying Q4 EPS of approximately $0.23–0.33; organic sales growth guidance tightened and was revised up from +1%–+3% to +3.0%, meaning Q4 organic sales grew by at least +3%. UBS accordingly raised its FY26 EPS model from $2.21 to $2.48, while maintaining organic sales growth forecast at +2.9% unchanged. Tax and share count assumptions remained at 36% effective tax rate and 365 million weighted average shares outstanding. Regarding FY27 Outlook: Management provided an initial direction, expecting organic sales growth of +3%–+5% and adjusted operating margin of 12.5%–13% (excluding potential tariff refunds). UBS raised its FY27 EPS forecast from $2.69 to $3.27, expecting organic sales growth of +3.7%. Management explained providing FY27 outlook early was to demonstrate the path to future margin improvements and give the market clear expectations for FY27 form. Short-term Disruptions and Regional Dynamics: Impact of Middle East business interruption in Q4 is expected to be greater than Q3, dragging Q4 sales by about 2 percentage points and EPS by about $0.06. In Travel Retail, airport interruptions in Q3 occurred as expected, but Hainan retail performance was stronger than expected, while other Asian markets were somewhat weak. Q4 growth support points include: reduced China travel retail disruption will drive APAC acceleration; Americas business may improve slightly; China mainland growth likely to maintain status quo. Valuation and Rating: Based on P/E and EV/EBITDA weighted valuation, target price raised from $75 to $85. Upside comes from earnings forecast revision and valuation rollover, partially offset by peer valuation compression. Calculating based on current price of $79.30, expected 12-month stock appreciation is 7.2%, plus dividend yield of 1.9%, total return approximately 9.0%, just slightly above the 8.9% market return assumption, thus maintaining Neutral.

Analysis framework

UBS adopts a 'Earnings Forecast—Valuation—Return' three-step method: First, break down the company's latest performance guidance into quarterly EPS, organic sales, and margin assumptions; second, quantify macro and geopolitical disruptions (e.g., Middle East conflict, China travel retail volatility) into quarterly forecasts; third, use Forward P/E and EV/EBITDA weighted valuation to derive target price, compare 12-month return implied by target price with Market Return Assumption (MRA) to decide maintaining Neutral.

Methodology notes

• Valuation Method

  Weighted Forward P/E and EV/EBITDA Valuation

  The report considers both Price-to-Earnings (P/E) and Enterprise Value/EBITDA valuation metrics and determines the target price using a weighted average; this method reflects earnings expectations while also accounting for company leverage and cash flow generation capabilities.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• The Estée Lauder Companies Inc (EL.US)

  Report coverage target, directly benefits from guidance raise and margin improvement expectations

  Strengths

  Q3 results strong, FY26 guidance raised, clear FY27 organic sales and margin targets; Hainan travel retail better than expected

  Weaknesses

  Visibility still insufficient; Middle East conflict, China travel retail regional divergence, weak China mainland growth, tariff refund uncertainty

  Risks

  Geopolitics (Middle East), macro volatility, consumer preference shifts, competition intensity, execution miss, FX and commodities volatility, M&A and capital allocation

Key data

• FY26 EPS Guidance$2.35–2.45Previously $2.05–2.25
• FY26 Organic Sales Growth Guidance+3.0%Previously +1%–+3%
• UBS FY26 EPS Forecast$2.48Raised from $2.21
• FY27 Initial Organic Sales Growth+3%–+5%Management initial guidance
• FY27 Adjusted Operating Margin Target12.5%–13.0%Excluding potential tariff refunds
• UBS FY27 EPS Forecast$3.27Raised from $2.69
• Middle East Conflict Impact on Q4Sales -2pp, EPS -$0.06Impact greater than Q3
• Effective Tax Rate / Weighted Shares Outstanding36% / 365 MillionRemained unchanged
• Target Price$85.00Raised from $75
• Expected 12-Month Stock Appreciation / Total Return7.2% / Approx. 9.0%Market Return Assumption 8.9%
• Current Share Price$79.30As of May 1, 2026

Impact & implications

The report believes Estée Lauder's fundamentals are stabilizing: guidance raises show improvement in company execution and demand side, FY27 margin targets also provide a path for earnings recovery. However, Middle East conflict, regional divergence in China travel retail, and overall macro uncertainty mean the sustainability of performance improvement still needs observation. On valuation, target price rise mainly relies on earnings forecast correction, while peer valuation compression partly offset this positive effect; current implied return just exceeds market benchmark, still insufficient to support more aggressive ratings.

Risks

• Consumer preferences or regulatory changes related to HPC products
• Government trade and tax policy changes
• Macro trends, interest rates and credit environment fluctuations
• Industry competition intensifies, including private label competition
• Changes in customer or supplier relationships
• Commodity costs and FX fluctuations
• Company R&D, sales marketing and productivity improvement execution failure
• M&A, joint ventures, divestitures and cash allocation strategy changes

What to watch

• Whether FY26 Q4 organic sales can reach at least +3% and hit EPS guidance range
• Execution of FY27 initial guidance (organic sales +3%–+5%, Adjusted Operating Margin 12.5%–13%)
• Subsequent impact of Middle East conflict on sales and profits
• Potential progress and timing of tariff refunds
• China travel retail (especially Hainan) and China mainland demand trends
• Magnitude of Americas business improvement and peer valuation changes